CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 8-K Event Bylaws or fiscal year change
- 8-K Event Executive or director change
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $3.68 ($11,030)
- 4 Open-market buy President and CEO bought 16,500 shares at $3.60 ($59,400)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $4.27 ($4,270)
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Option exercise President and CEO acquired 75,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 6,500 shares at $4.83 ($31,395)
- 4 Option exercise Chief Operating Officer acquired 4,600 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 5,000 shares (option exercise)
- 3/A Insider 3/A
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $5.52 ($8,273)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 19 of 49 · 978 filings